Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease. (Q52801895)
Jump to navigation
Jump to search
scientific article published on 17 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease. |
scientific article published on 17 January 2017 |
Statements
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease (English)
Ambrogio Orlando
Rosalba Orlando
Francesco Ciccia
Sara Renna
Aroldo Rizzo
17 January 2017